Emergent BioSolutions Inc 2022 Annual Report with Sustainability Disclosures
Company: Emergent BioSolutions Inc
Sector: Manufacturing
Country: United States
Year: 2022
Type: Annual Report with Sustainability Disclosures
Pages: 160
The report records 2022 total revenues of $1,120.9 million, down 37% from 2021. It highlights the acquisition of the exclusive worldwide rights to TEMBEXA and related assets. ESG governance is described as committee-led, with the strategy influenced by TCFD and SASB standards. The company also reports approximately 2,500 employees at year-end.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.